-
1
-
-
75749134040
-
Improving the efficacy of combined modality anticancer therapy using HPMA copolymer-based nanomedicine formulations
-
Lammers T. Improving the efficacy of combined modality anticancer therapy using HPMA copolymer-based nanomedicine formulations. Adv. Drug Deliv. Rev. 62, 203-230 (2010).
-
(2010)
Adv. Drug Deliv. Rev.
, vol.62
, pp. 203-230
-
-
Lammers, T.1
-
2
-
-
75749149269
-
HPMA copolymers: Origins, early developments, present, and future
-
Kopecek J, Kopecková P. HPMA copolymers: origins, early developments, present, and future. Adv. Drug Deliv. Rev. 62, 122-149 (2010).
-
(2010)
Adv. Drug Deliv. Rev.
, vol.62
, pp. 122-149
-
-
Kopecek, J.1
Kopecková, P.2
-
3
-
-
84865370343
-
Combination drug delivery approaches in metastatic breast cancer
-
doi:10.1155/2012/915375 Epub ahead of print
-
Lee JH, Nan A. Combination drug delivery approaches in metastatic breast cancer. J. Drug Deliv. doi:10.1155/2012/915375 (2012) (Epub ahead of print).
-
(2012)
J. Drug Deliv.
-
-
Lee, J.H.1
Nan, A.2
-
4
-
-
84859944275
-
Dextran conjugates in drug delivery
-
Varshosaz J. Dextran conjugates in drug delivery. Expert Opin. Drug Deliv. 9, 509-523 (2012).
-
(2012)
Expert Opin. Drug Deliv.
, vol.9
, pp. 509-523
-
-
Varshosaz, J.1
-
5
-
-
78650342641
-
Chitosan mediated targeted drug delivery system: A review
-
Patel MP, Patel RR, Patel JK. Chitosan mediated targeted drug delivery system: A review. J. Pharm. Pharm. Sci. 13, 536-557 (2010).
-
(2010)
J. Pharm. Pharm. Sci.
, vol.13
, pp. 536-557
-
-
Patel, M.P.1
Patel, R.R.2
Patel, J.K.3
-
6
-
-
77956871233
-
Chitosan as a carrier for targeted delivery of small interfering RNA
-
Rudzinski WE, Aminabhavi TM. Chitosan as a carrier for targeted delivery of small interfering RNA. Int. J. Pharm. 399, 1-11 (2010).
-
(2010)
Int. J. Pharm.
, vol.399
, pp. 1-11
-
-
Rudzinski, W.E.1
Aminabhavi, T.M.2
-
7
-
-
80053313377
-
Recent advances of chitosan nanoparticles as drug carriers
-
Wang JJ, Zeng ZW, Xiao RZ et al. Recent advances of chitosan nanoparticles as drug carriers. Int. J. Nanomedicine 6, 765-774 (2011).
-
(2011)
Int. J. Nanomedicine
, vol.6
, pp. 765-774
-
-
Wang, J.J.1
Zeng, Z.W.2
Xiao, R.Z.3
-
8
-
-
42749091133
-
Polymer-drug conjugates: Recent development in clinical oncology
-
Li C, Wallace S. Polymer-drug conjugates: Recent development in clinical oncology. Adv. Drug Deliv. Rev. 60, 886-898 (2008).
-
(2008)
Adv. Drug Deliv. Rev.
, vol.60
, pp. 886-898
-
-
Li, C.1
Wallace, S.2
-
9
-
-
33748323064
-
Poly(g,l-glutamic acid)-cisplatin conjugate effectively inhibits human breast tumor xenografted in nude mice
-
Yea H, Jina L, Hua R et al. Poly(g,l-glutamic acid)-cisplatin conjugate effectively inhibits human breast tumor xenografted in nude mice. Biomaterials 27, 5958-5965 (2006).
-
(2006)
Biomaterials
, vol.27
, pp. 5958-5965
-
-
Yea, H.1
Jina, L.2
Hua, R.3
-
10
-
-
77953889643
-
New biological functions and applications of high-molecular-mass poly-g-glutamic acid
-
Poo H, Park C, Kwak M-S et al. New biological functions and applications of high-molecular-mass poly-g-glutamic acid. Chem. Biodivers. 7, 1555-1562 (2010).
-
(2010)
Chem. Biodivers.
, vol.7
, pp. 1555-1562
-
-
Poo, H.1
Park, C.2
Kwak, M.-S.3
-
11
-
-
78149245451
-
Inhibition of brain tumor growth by intravenous poly(b-l-malic) acid nanobioconjugate with pH-dependent drug release
-
Ding H, Inoue S, Ljubimov AV et al. Inhibition of brain tumor growth by intravenous poly(b-l-malic) acid nanobioconjugate with pH-dependent drug release. Proc. Natl Acad. Sci. USA 107, 18143-18148 (2010).
-
(2010)
Proc. Natl Acad. Sci. USA
, vol.107
, pp. 18143-18148
-
-
Ding, H.1
Inoue, S.2
Ljubimov, A.V.3
-
12
-
-
79951847458
-
Nanobioconjugate inhibition of HER2/neu signaling and synthesis provides efficient mouse breast cancer treatment
-
Inoue S, Ding H, Portilla-Arias J et al. Nanobioconjugate inhibition of HER2/neu signaling and synthesis provides efficient mouse breast cancer treatment. Cancer Res. 71, 1454-1464 (2011).
-
(2011)
Cancer Res.
, vol.71
, pp. 1454-1464
-
-
Inoue, S.1
Ding, H.2
Portilla-Arias, J.3
-
13
-
-
84857089600
-
Novel nanobioconjugate inhibiting EGFR expression in triple negative breast cancer
-
Inoue S, Patil R, Portilla-Arias J et al. Novel nanobioconjugate inhibiting EGFR expression in triple negative breast cancer. PLoS ONE 7(2), E3107 (2012).
-
(2012)
PLoS ONE 7
, vol.2
-
-
Inoue, S.1
Patil, R.2
Portilla-Arias, J.3
-
14
-
-
78549283950
-
Temozolomide delivery to tumor cells by a multifunctional nano vehicle based on poly(b-l-malic acid
-
Patil R, Portilla-Arias J, Ding H et al. Temozolomide delivery to tumor cells by a multifunctional nano vehicle based on poly(b-l-malic acid). Pharm. Res. 27, 2317-2329 (2010).
-
(2010)
Pharm. Res.
, vol.27
, pp. 2317-2329
-
-
Patil, R.1
Portilla-Arias, J.2
Ding, H.3
-
15
-
-
84855881402
-
Exploiting the cancer genome: Strategies for the discovery and clinical development of targeted molecular therapeutics
-
Yap TA, Workman P. Exploiting the cancer genome: Strategies for the discovery and clinical development of targeted molecular therapeutics. Annu. Rev. Pharmacol. Toxicol. 52, 549-573 (2012).
-
(2012)
Annu. Rev. Pharmacol. Toxicol.
, vol.52
, pp. 549-573
-
-
Yap, T.A.1
Workman, P.2
-
16
-
-
84863393080
-
Intratumor heterogeneity and branched evolution revealed by multiregion sequencing
-
Gerlinger M, Rowan AJ, Horswell S et al. Intratumor heterogeneity and branched evolution revealed by multiregion sequencing. N. Engl. J. Med. 366, 883-892 (2012).
-
(2012)
N. Engl. J. Med.
, vol.366
, pp. 883-892
-
-
Gerlinger, M.1
Rowan, A.J.2
Horswell, S.3
-
17
-
-
84863116087
-
Comparative oncogenomics identifies breast tumors enriched in functional tumor initiating cells
-
Herschkowitz JI, Zhao W, Zhang M et al. Comparative oncogenomics identifies breast tumors enriched in functional tumor initiating cells. Proc. Natl Acad. Sci. USA 109, 2778-2783 (2012).
-
(2012)
Proc. Natl Acad. Sci. USA
, vol.109
, pp. 2778-2783
-
-
Herschkowitz, J.I.1
Zhao, W.2
Zhang, M.3
-
18
-
-
84868191543
-
The role of targeted therapy and biomarkers in breast cancer treatment
-
10.1007/s10585-012-9496-y Epub ahead of print
-
Stopeck AT, Brown-Glaberman U, Wong HY et al. The role of targeted therapy and biomarkers in breast cancer treatment. Clin. Exp. Metastasis doi:10.1007/s10585-012-9496-y (2012) (Epub ahead of print).
-
(2012)
Clin. Exp. Metastasis
-
-
Stopeck, A.T.1
Brown-Glaberman, U.2
Wong, H.Y.3
-
19
-
-
84863099046
-
Cell-penetrating peptides: Breaking through to the other side
-
Koren E, Torchilin VP. Cell-penetrating peptides: breaking through to the other side. Trends Mol. Med. 18, 385-393 (2012).
-
(2012)
Trends Mol. Med.
, vol.18
, pp. 385-393
-
-
Koren, E.1
Torchilin, V.P.2
-
20
-
-
79956071007
-
Polymalic acid peptide copolymers: Design and optimization for endosomolytic drug delivery
-
Ding H, Portilla-Aries J, Patil R, Black KL, Ljubimova JY, Holler E. Polymalic acid peptide copolymers: design and optimization for endosomolytic drug delivery. Biomaterials 32, 5269-5278 (2011).
-
(2011)
Biomaterials
, vol.32
, pp. 5269-5278
-
-
Ding, H.1
Portilla-Aries, J.2
Patil, R.3
Black, K.L.4
Ljubimova, J.Y.5
Holler, E.6
|